SP

Active Director Director DIN 07300040
DIN 07300040 First appointment Oct 2015 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2015
Shareholding value •••• Premium profile

About Sat Pal

Data last updated:

Sat Pal is a Director at Constant Remedies Private Limited (since 2015). The company operates in Healthcare. Constant Remedies Private Limited reported revenue of ₹1.43 Cr (FY 2025).

DIN 07300040
Primary Designation Director
Industry Healthcare
First Appointment 03 Oct 2015
Oldest Company Age 19 yrs
Largest company Constant Remedies Private Limited · ₹1.43 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Constant Remedies Private Limited U24232CH2007PTC030688
Director03 Oct 20152007₹1.43 Cr (FY 2025)Active

Board colleagues of Sat Pal

NameDINCompanyDesignation
Ashish Mittal00723357Constant Remedies Private LimitedDirector

Directorship timeline

Open interactive timeline →
Constant Remedies Private Limited
Premium access

Shareholding and investment profile for Sat Pal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sat Pal

Sat Pal currently holds 1 directorship: Constant Remedies Private Limited (Director, since 03 Oct 2015, revenue ₹1.43 Cr (FY 2025)).

Sat Pal was first appointed on 03 Oct 2015 as Director at Constant Remedies Private Limited.

The current boards of Sat Pal's companies include Ashish Mittal (Constant Remedies Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available